By Gregory T. Huang
Seattle-based Cell Therapeutics announced it has teamed up with Spectrum Pharmaceuticals of Irvine, CA, to create a 50-50 joint venture, RIT Oncology, to commercialize and develop the cancer drug Zevalin. The drug for non-Hodgkin’s …
www.xconomy.com/seattle/2008/11/26/cell-therapeutics-spectrum-form-joint-venture/

Comments are closed.